The pathophysiology of rosacea

Giornale Italiano di Dermatologia e Venereologia

Volumn 144, Issue 6, 2009, Pages 663-671

  Mc Aleer, M A ^a   Lacey, N ^a   Powell, F C ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Demodex; Innate immunity; Pathogenesis UV radiation; Rosacea, etiology

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CORTICOTROPIN RELEASING FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; KALLIKREIN 5; NEUROPEPTIDE; REACTIVE OXYGEN METABOLITE; SOMATOSTATIN; SUBSTANCE P; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR; VASCULOTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

BLOOD VESSEL REACTIVITY; CLINICAL FEATURE; DEMODEX; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INNATE IMMUNITY; ONSET AGE; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; ROSACEA; ULTRAVIOLET RADIATION;

EID: 77949623860     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R et al. Standard Classification of rosacea: report of the National Rosacea Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002;46:584-7
2. National Rosacea Society [Internet]. Available from www.nrs.org [cited 2009, Oct 27].
3. Berg M, Lidén S. An Epidemiological Study of Rosacea. Acta Derm Venereol (Stockh) 1989;69:419-23.
4. McAleer MA, Fitzpatrick P, Powell FC. Papulopustular rosacea: prevalence and relationship to photodamage. J Am Acad Dermatol. In press.
5. Marks R, Harcourt-Webster JN. Histopathology of rosacea. Arch Dermatol 1969;100:683-9.
6. Basta-Juzabasic̀ A, Marinoric T, Dobric I, Bolanca-Brumber S, Sencar J. The possible role of skin surface lipids in rosacea with epithelioid granulomas. Acta Med Croatica 1992;46:119-23.
7. Roth AM. Demodex folliculorum in hair follicles of eyelid skin. Ann Opthalmol 1979;11:37-40.
8. Buechner SA. Rosacea: an update. Dermatology 2005;210:100-8.
9. Forton F, Seys B. Density of Demodex folliculorum in rosacea: A case-control study using a standardised skin-surface biopsy. Br J Dermatol 1993;128:650-9.
10. Powell FC. Rosacea and the pilosebaceous follicle. Cutis 2004;74:9-12; 32-4.
11. Rufli T, Buchner S. T-cell subsets in acne rosacea lesions and the possible role of Demodex folliculorum. Dermatologica 1984;169:1-5.
12. Georgala S, Katoulis A, Kylafis G, Koumantaki-Mathioudaki E, Georgala C, Aroni K. Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea. J Eur Acad Dermatol Venereol 2001;15:441-5.
13. Grosshans E, Dungler T, Kien TT, Kremer M. Demodex folliculorum and rosacea: experimental and immunological studies. Hautkr 1980;55:121.
14. Powell FC. Rosacea. N Eng J Med 2005;352:793-803.
15. McAleer MA, Fitzpatrick P, Powell. Rosacea prevalence and pathogenesis. Br J Dermatol 2008;159:24-69.
16. Bielenberg DR, Bucana CD, Sanchez R, Donawho CK, Kripke ML, Fidler IJ. Molecular regulation of UVB-induced cutaneous angioenesis. J Invest Dermatol 1998;111:864-72.
17. Fimmel S, Glass E, Zouboulis CC. Neuropeptides and UV radiation are possible mediators of inflammation in rosacea. J Invest Dermatol 2005;124(Suppl):A16.
18. Pinnell SR. Cutaneous photodamage, oxidative stress,and topical antioxidant protection. J Am Acad Dermatol 2003;48:1-19.
19. Nam E, Suzuki T, Moriyama M, Inomata K, Hayashi A, Arakane K et al. Functional changes induced by chronic UVA irridiation to cultured human dermal fibroblasts. Br J Dermatol 2005;153(Suppl 2):6-12.
20. Yamasaki K, Gallo RL. The molecular pathology of rosacea. J Dermatol Sci 2009;55:77-81.
21. Oztas MO, Balk M, Ogüs E, Bozkurt M, Ogüs IH, Ozer N. The role of free oxygen radicals in the aetiopathogenesis of rosacea. Clin Exp Dermatol 2003;28:188-92.
22. Baz K, Cimen MY, Kokturk A, Asian G, Ikizoglu G, Demirseren DD et al. Plasma reactive oxygen specied activity and antioxidant potential levels in rosacea patients: correlation with seropositivity to Helicobacter pylori. Int J Dermatol 2004;43:494-7.
23. Baker Ö, Yuksel ZDM, Hakler G, Sanisoglu Y. The effect of azithromycin on reactive oxygen species in rosacea. Clin Exp Dermatol 2007;32:197-200.
24. Sibenge S, Gawkrodger D. Rosacea: A study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol 1992;26:590-3.
25. Guzman-Sanchez DA, Ishiuji Y, Patel T, Fountain J, Chan YH, Yosipovitch G. Enhanced skin blood flow and sensitivity to noxious heat stimuli in papulopustular rosacea. J Am Acad Dermatol 2007;57:800-5.
26. Shanler SD, Ondo AL. Successful treatment of erythema and flushing of rosacea using a topically applied selective alpha-1-adrenergic receptor agonist, oxymetazoline. Arch Dermatol 2007;143:1369-71.
27. Gomaa AH, Yaar M, Eyada MM, Bhawan J. Lymphangiogenesis and angiogenesis in non-phymatous rosacea. J Cutan Pathol 2007;34:748-53.
28. Lonne-Rahn S, Nordlind K, Wiegleb Edstrõm D, Ros AM, Berg M. Laser treatment of rosacea. A pathoetiological study. Arch Dermatol 2004;140:1345-9.
29. Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol 1968;80:170-7.
30. Griesemer R. Emotionally triggered disease in dermatological practice. Psychiar Ann 1978;8:49-56.
31. Puchalski Z. Psychosomatic aspects in patients with alopecia areata, rosacea, and lichen rubber planus. Z Hautkr 1983;58:1648-54.
32. Steinhoff M, Stander S, Seeliger S, Ansel JC, Schmelz M, Luger T. Modem aspects of cutaneous neurogenic inflammation. Arch Dermatol 2003;139:1479-88.
33. Powell FC, Corbally N, Powell D. Substance P and rosacea. J Am Acad Dermatol 1993;28:132-3.
34. K,rkç,o lu N, Alaybeyi F. Substance P immunoreactivity in rosacea. J Am Acad Dermatol 1991;25:725-6.
35. Wollina U. Rhinophyma - unusual expression of simple-type keratins and S100A in sebocytes and abundance of VIP receptor-positive dermal cells. Histol Histopath 1996;11:111-5.
36. Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M. Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ. Physiol Rev 2006;86:1309-79.
37. Scholzen T, Armstrong CA, Bunnett NW, Leger TA, Olerud JE, Ansel JC. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998;7:81-96.
38. Piérard-Franchimont C, Quatresooz P, Piérard GE. Incidental Control of Rosacea by Somatostatin. Dermatology 2003;206:249-51.
39. Murphy A, Buchanan KD, Powell FC. Vasoactive intestinal peptide release is not a factor in roscaea. Br J Dermatol 1997;137:(Suppl 50);27.
40. Schauber J, Gallo RL. Atimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2008;122:261-6.
41. Yamasaki K, Di Nardo A, Barden A, Marakami M, Ohtake T, Coda A et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007;13:975-80.
42. Atherton JC, Blaser MJ. Coadaption of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 2009;119:2475-87.
43. Rebora A, Drago F, Picciotto A. Helicobacter pylori in patients with rosacea. Am J Gastroenterol 1994;89:1603-4.
44. Utas S, Ozbakir O, Turasan A, Utas C. Helicobacter pylori eradication treatment reduced the severity of rosacea. J Am Acad Deramtol 1999;40:433-5.
45. Szlacheic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol 2002;16:328-33.
46. Argenziano G, Donnarumma G, Iovene MR, Arnese P, Baldassarre A, Baroni A. Incidence of anti-Helicobactor pylori and anti-CagA antibodies in rosacea patients. Int J Dermatol 2003;42:601-4.
47. Gurer MA, Erel A, Erbas D, Caglar K, Atahan C. The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea. Int J Dermatol 2002;41:768-70.
48. Sharma V, Lynn A, Kaminski M, Vasudeva R, Howden C. A study of the prevalence of Helicobacter pylori infection and other markers of upper gasrointestinal tract disease in patients with rosacea. Am J Gastroenterol 1998;93:220-2.
49. Bamford J, Tilden R, Blankush J, Gangeness D. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 1999;135:659-63.
50. Smith Jr MF, Mitchell A, Li G, Ding S, Fitzmaurice AM, Ryan K et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are requires for Helicobacter pylori induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 2003;278:32552-60.
51. Desch C, Nutting WB. Demodex folliculorum (Simon) and D. brevis Akbulatova of Man: Redescription and Reevaluation. J Parasitol 1972;58:169-177.
52. Nutting W. Hair follicle mites (acari: demodicidae) of man. Int J Dermatol 1976;15:79-97.
53. Nutting W, Green AC. Pathogenesis associated with hair follicle mites (Demodex spp.) in Australian Aborigines. Br J Dermatol 1972;94:307-12.
54. Nom M.S. The follicle mite (Demodex folliculorum). Eye Ear Nose Throat Mon 1972;51:187-91.
55. Desch CE, Nutting WA. B Morphology and functional anatomy of Demodex folliculorum (Simon) of man. Acarologia 1977;19:422-62.
56. Spickett SG. Studies on Demodex folliculorum Simon. Parasitology 1961;51:181-92.
57. Erbagci, Z, Özgöztasi, O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol 1998;37:421-5.
58. Rufli T, Mumcuoglu Y. The hair follicle mites Demodex folliculorum and Demodex brevis: Biology and Medical Importance. A review. Dermatologica 1981;162:1-11.
59. Ayres S. Jr., Anderson NP. Demodex folliculorum its role in the etiology of acne rosacea. Arch Dermatol Syphilol 1932;25:89-98.
60. Abd-el-al AM, Bayoumy AMS, Abou Salem EA. A study of Demodex folliculorum in rosacea. J Eygp Soc Parasitol 1997;27:183-95.
61. Bonnar E, Eustace P, Powell FC. The Demodex mite population in rosacea. Am Acad Dermatol 1993;28:443-8.
62. Forton F, Seys B. Demodex folliculorum and topical therapy: arcaricidal activity evaluated by standard skin surface biopsy. Br J Dermatol 1998;138:461-6.
63. Forton F, Song M. Limitations of standardised skin surface biopsy in measurement of the density of Demodex folliculorum. A case report. Br J Dermatol 1998;139:697-700.
64. Forton F, Germaux MA, Brasseur T, De Liever A, Laporte M, Mathys C et al. Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice. J Am Acad Dermatol 2005;52:74-87.
65. Marks R, Dawber RPR. Skin surface biopsy: an improved technique for the examination of the homy layer. Br J Dermatol 1972;84:117-23.
66. Rufli T, Mumcuoglu Y, Cajacob A, Büchner, S. Demodex folliculorum: Zur Ätiopathogenesis und Therapie der Rosacea und perioral Dermatitis. Dermatologica 1981;162:12-26.
67. Lacey N, Delaney S, Kavanagh K, Powell FC. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol 2007;157:474-81.
68. Betsou, F., J.M. Sueur, and J. Orfila, Serological investigation of Chlamydia trachomatis heat shock protein 10. Infect Immun 1999;67:5243-6.
69. Wallin RP, Lundqvist A, Moré SH, von Bonin A, Kiessling R, Ljunggren HG. Heat-shock proteins as activators of the innate immune system. Trends Immunol 2002;23:130-5.?
70. van Eden W, van der Zee R, Prakken B. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 2005;5:318-30.